Fragile X Syndrome Reversed In Adult Mice

New research published this month in Neuron has found a newly developed mGlu5 inhibitor, CTEP, is effect at reversing many symptoms associated with Fragile X syndrome in adult mouse models. While CTEP isn’t currently being developed for humans, the researchers have pointed out that their findings are significant for understanding the condition. FXS, they suggest, is not the result of an irreversible disruption of brain development.

Read More